Mohammad Al-Essa

Mohammad Al-Essa

Auto-generated profile, based on publicly available information

Mohammad Al-Essa

Department of Internal Medicine, The University of Jordan, Amman 11942, Jordan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Open Access Rheumatology: Research and Reviews
Verified
Journal Article
Open access
PDF file
OHOla Hijjaw
Ola Hijjaw
MAMohammad Alawneh
Mohammad Alawneh
KOKhaled Ojjoh
Khaled Ojjoh
HAHazem Abuasbeh
Hazem Abuasbeh
AAAhmad Alkilany
Ahmad Alkilany
Saif Aldeen AlryalatSaif Aldeen Alryalat
Saif Aldeen Alryalat
Background and objective: Xerostomia is a subjective measure of dry mouth, while hyposalivation is an objective measure of reduced saliva flow rate. In this study, we aim to assess the association between commonly used xerostomia scoring systems, with different hyposalivation measures among Sjogren Syndrome (SS) patients. Methods: In a cohort of SS patients, we assessed xerostomia using Xerostomia index, clinical oral dryness scale (CODS), and the European League Against Rheumatism SS Patient-Reported Index (ESSPRI), and we assessed hyposalivation using unstimulated whole saliva flow (UWS), stimulated whole saliva flow (SWS), and stimulated parotid flow (SPF). We analyzed the association between xerostomia and hyposalivation using association tests in SPSS. Results: We included a total of 49 patients in this study, of which 34 (68%) had primary SS, and 15 (32%) had secondary. CODS was significantly correlated with SWS (P=0.048), with a negative correlation coefficient of 0.216, and with SPF (P=0.009), with a negative correlation coefficient of 0.291. The dryness domain of ESSPRI was significantly correlated with UWS (P=0.031) with a negative correlation coefficient of 0.233.
Conclusion:
CODS is the scoring system with the highest correlation with hyposalivation, particularly SWS and SPF, followed by ESSPRI dry domain, which is correlated with UWS. Xerostomia index is not correlated with hyposalivation.

1 April 2019 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
SASameeha Alshelleh
Sameeha Alshelleh
IAIzzat AlAwwa
Izzat AlAwwa
AOAshraf Oweis
Ashraf Oweis
Saif Aldeen AlryalatSaif Aldeen Alryalat
Saif Aldeen Alryalat
MAMohammad Al-Essa
Mohammad Al-Essa
KAKarem Alzoubi
Karem Alzoubi
Background: Several epidemiological studies have assessed various components of Metabolic Syndrome (MS) in different populations, but only a few compared the prevalence of metabolic syndrome in dialysis and transplant patients. Aim: The aim of this study is to compare the prevalence of MS in dialysis and transplant patients. Two groups of patients were included; hemodialysis patients and patients with transplanted kidneys. Methods: Demographic and clinical history, and lab data were collected. A total of 108 patients were included in this study with a mean age of 52.3 (±16.29) years. Study groups included 61 (56.5%) dialysis patients, and 47 (43.5%) patients with transplanted kidneys. Results: Upon comparing the prevalence of metabolic syndrome between the two study groups, transplant patients had significantly lower prevalence of metabolic syndrome (34%) compared to that of metabolic syndrome in patients on dialysis (55.7%; P=0.016). Conclusion: As metabolic syndrome plays an important role in the pathology of elderly patients, especially those with transplanted kidneys, such findings indicate the need for close monitoring of kidney transplant patients for the manifestations of metabolic syndrome.

12 September 2019 in Current Respiratory Medicine Reviews
Verified
Journal Article
Open access
PDF file
Saif Aldeen AlryalatSaif Aldeen Alryalat
Saif Aldeen Alryalat
ANAnas Abu Nassar
Anas Abu Nassar
FTFaris Tamimi
Faris Tamimi
EAEsraa Al-Fraihat
Esraa Al-Fraihat
LALama Assaf
Lama Assaf
MAMohammad Al-Essa
Mohammad Al-Essa
Background: Open access (OA) publishing is rapidly emerging in almost all disciplines, with variable intensity and effect on the discipline itself. The move toward OA is also observed in the field of respiratory and pulmonology, where both OA data repositories and OA journals are rapidly emerging. Objective: we aim to study the open-access status of respiratory and pulmonology journals and the impact of the open-access status on journal indices. Methods: We collected journal’s data from Scopus Source List on 1st of November 2018. We filtered the list for respiratory and pulmonology journals. Open Access Journals covered by Scopus are recognized as Open Access if the journal is listed in the Directory of Open Access Journals (DOAJ) and/or the Directory of Open Access Scholarly Resources (ROAD). For each journal, we used several metrics to measure its strength, and then we compared these metrics between OA and non- OA journals. Results: There were 125 respiratory and pulmonology journals, a number that has increased by 12.6% since 2011. Moreover, the percentage of OA journals has increased from 21.6% to 26.4% during the same period. Non-OA journals have significantly higher scholarly output (p= 0.033), but OA journals have significantly higher percentage of citation (p= 0.05). Conclusion: Publishing in OA journals will yield a higher citation percentage compared to non-OA journals. Although this should not be the only reason to publish in an OA journal, it is still an important factor to decide where to publish.

27 April 2018 in Current Respiratory Medicine Reviews
Verified
Journal Article
Closed access
PDF file
Saif Aldeen AlryalatSaif Aldeen Alryalat
Saif Aldeen Alryalat
MAMohammad Al-Essa
Mohammad Al-Essa
RGRawan Ghazal
Rawan Ghazal
EAEnas Abusalim
Enas Abusalim
DMDia Mobaideen
Dia Mobaideen
NONathir Obaidat
Nathir Obaidat
Background: Sarcoidosis is a granulomatous disease that primarily affects the lung and lymphatic systems of the body. The Chest X-ray (Roentgenology) is the most common first imaging modality used in the diagnostic approach and follow-up of sarcoidosis, and is still used to determine the stage of sarcoidois based on the classification system proposed by Scadding (1961). Objective: We will assess the relation between different chest x-ray findings in sarcoidosis patients and both, demographic variables of sarcoidosis patients (age, gender, and race), along with different Scadding stages. Method: We included data regarding cases in the case-control ACCESS study, including demographic and clinical data, in addition to X-ray findings. From those with a biopsy-confirmed diagnosis of sarcoidosis in the ACCESS trial, we excluded patients with diseases that might contribute to X-ray abnormalities, including cardiac and respiratory non-sarcoidosis diseases (e.g. asthma and chronic bronchitis). We also excluded sarcoidosis patients without lung involvement. Results: A total of 499 patients were included in this study, of which 195 (39.1%) were men and 304 (60.9%) were women. We found that pleural abnormalities are most commonly associated with Scadding stage 2 (42.9%, p= 0.001), whereas Scadding stage 4 is associated with hilar retraction (52.8%, p< 0.001), bullae and bleps (73.7%, p< 0.001), and pulmonary artery enlargement (66.7%, p< 0.001). Finally, we also observed significant relations between demographic variables (age, gender, and race) and different imaging findings. Conclusion: Upon interpreting chest X-ray of sarcoidosis patients, patients' age, gender, and race should be kept in mind, as demographic variables are associated with chest X-ray findings in those patients. Moreover, each Scadding stage is associated with several findings on chest X-ray in sarcoidosis patients and should be interpreted accordingly.